Indero

What Indero does

Indero is a privately held, Montreal-headquartered contract research organization (CRO) founded in 2000 (formerly Innovaderm Research, rebranded to Indero in March 2025) that delivers end-to-end clinical trial services exclusively for dermatology and rheumatology indications, with a stated focus on immune-mediated diseases. The company operates an integrated three-brand ecosystem consisting of the Indero CRO services platform, the Innovaderm Clinical Research Unit (CRU) — a dedicated dermatology site with a 90,000+ patient database — and Clinago, a proprietary patient recruitment platform with 22,000+ pre-qualified patients and direct integrations with 100+ patient advocacy groups. Its technology stack combines multi-vendor EDC/RTSM/eCOA systems (Medidata, Medrio, Veeva, Signant Health, Suvoda), Oracle Argus Safety for pharmacovigilance, Spotfire for safety analytics, and a centralized data lake with Power BI dashboards, supported by advanced dermatological imaging (DermaScan, Visia-CR, LifeViz, VivoSight OCT) and a recently launched quantitative gene expression method for topical drug evaluation.

The company serves biotech and pharmaceutical sponsors running dermatology and rheumatology trials, with 500+ clinical trials conducted, 3,100+ investigators in its network, and active operational coverage across North America, Europe, Latin America, and Asia-Pacific. Revenue is generated through project-based professional services contracts — including early and late phase trial management, study design, site selection, patient recruitment, clinical monitoring, biometrics, pharmacovigilance, medical writing, and regulatory consulting — with no public pricing disclosed. Notable outcomes include a Phase 3 atopic dermatitis program reaching 200% enrollment within five months, a systemic sclerosis trial achieving a 4% discontinuation rate versus an industry average of 15-20%, and a CNS Phase 2 biometrics data rescue that enabled Phase 3 program continuation.

Name

Indero

Legal name

Indero (legal entity designation not explicitly stated in available sources)

Website

https://inderocro.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

Indero is a dual-focus dermatology and rheumatology CRO providing end-to-end clinical trial services to biotech and pharmaceutical sponsors globally, operating an integrated ecosystem of CRO services, a dedicated clinical research unit, and a proprietary patient recruitment platform.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

akta.pro secondary industries

Clinical CROs (Phase I–IV) (HLAGAAAA), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG)

Keywords

• Clinical research services
• Dermatology clinical trials
• Rheumatology clinical trials
• Contract research organization
• Pharmacovigilance services

Headquarters

HQ city

Montréal

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Research Services (CRO): Full-service CRO providing end-to-end clinical trial services including early and late phase trial management, study design, site selection, patient recruitment, clinical monitoring, biometrics, pharmacovigilance, medical writing, regulatory consulting, and medical monitoring for dermatology and rheumatology studies. Revenue is generated through project-based professional services contracts with biotech and pharmaceutical sponsors.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

Indero is a dual-focus Contract Research Organization (CRO) providing end-to-end clinical trial services for dermatology and rheumatology immune-mediated diseases. The company delivers full-service clinical research including early and late phase trial management, study design, site selection, patient recruitment, clinical monitoring, biometrics, pharmacovigilance, medical writing, regulatory consulting, and medical monitoring for biotech and pharmaceutical sponsors globally. Services are supported by a proprietary patient recruitment platform (Clinago), advanced dermatological imaging capabilities, and an affiliated Clinical Research Unit (Innovaderm CRU) for single-center dermatology studies.

Product overview

Indero is a dual-focus CRO providing integrated clinical trial services for dermatology and rheumatology. The portfolio consists of three main offerings: (1) Indero CRO Services as the core clinical research organization platform offering end-to-end trial delivery; (2) Clinago as a proprietary patient recruitment module/platform connecting a database of 22,000+ patients to trial sites; and (3) Innovaderm CRU as the dedicated clinical research unit for dermatology studies. The company also offers specialized services including early and late phase trials, study design, site selection/management, patient recruitment, clinical monitoring, biostatistics and data management, medical writing, quality assurance, regulatory consulting, pharmacovigilance, and medical monitoring—all focused on immune-mediated dermatology and rheumatology conditions.

Differentiator

Problem solved

Functional benefit

Brands

• Clinago: Proprietary technology-enabled patient recruitment platform connecting patients to clinical trial sites, with a database of 22,000+ patients.

Products and services

• Indero CRO Services Full-service Contract Research Organization (CRO) specializing in clinical trial delivery for dermatology and rheumatology, offering end-to-end support from protocol design through data delivery with global operational capabilities across North America, Europe, Latin America, and Asia-Pacific. Serves biotech and pharmaceutical sponsors.
• Clinago Patient Recruitment Platform

Quantifiable outcome

• Phase 1 atopic dermatitis study successfully detected efficacy signal in 31-subject proof-of-concept cohort, enabling program progression to Phase 2
• +7 more outcomes

Named customers7 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability8 records

Feature7 records

Partnerships

18 partnerships are on record, tiered core and supporting.

• ClinagocoreTechnology or IntegrationClinago is Indero's proprietary patient-facing recruitment platform that connects 22,000+ pre-qualified patients to clinical trial sites. It features an integrated online pre-screener, secured patient profiles, study-specific landing pages, automated notifications, and real-time prescreening monitoring to optimize enrollment and reduce screen failures.
• National Psoriasis FoundationcoreStrategic or Co-development PartnerPatient advocacy group partnership for psoriasis clinical trial recruitment. Collaboration supports patient outreach and enrollment for dermatology studies in psoriasis and related conditions.
• National Alopecia Areata FoundationcoreStrategic or Co-development PartnerPatient advocacy group partnership supporting alopecia areata clinical trial recruitment and patient engagement for dermatology studies.
• National Eczema AssociationcoreStrategic or Co-development PartnerPatient advocacy group partnership supporting eczema (atopic dermatitis) clinical trial recruitment and patient awareness campaigns.
• HS ConnectcoreStrategic or Co-development PartnerPatient advocacy group partnership for hidradenitis suppurativa (HS) clinical trial recruitment, supporting enrollment in dermatology studies.
• Hope for HScoreStrategic or Co-development PartnerPatient advocacy group partnership for hidradenitis suppurativa, supporting clinical trial patient recruitment and awareness.
• ASENDHIcoreStrategic or Co-development PartnerPatient advocacy group partnership supporting scleroderma and systemic sclerosis clinical trial recruitment for rheumatology studies.
• Psoriasis FoundationcoreStrategic or Co-development PartnerPatient advocacy group partnership for psoriasis clinical trial recruitment, supporting dermatology clinical studies.
• DNB (Dermatology Nurses Association)coreStrategic or Co-development PartnerPatient advocacy group partnership supporting dermatology clinical trial recruitment and patient education.
• Psoriasis CollectivecoreStrategic or Co-development PartnerPatient advocacy group partnership for psoriasis clinical trial recruitment, supporting dermatology studies.
• 100+ Patient Advocacy Groups (Global)coreStrategic or Co-development PartnerIndero collaborates with over 100 patient advocacy groups across dermatology and rheumatology globally to support clinical trial recruitment, patient engagement, and community outreach.
• MedidatasupportingTechnology or IntegrationIndero uses Medidata as a qualified RTSM (Randomization and Trial Supply Management) and EDC (Electronic Data Capture) vendor for clinical trial data management.
• MedriosupportingTechnology or IntegrationIndero uses Medrio as a qualified EDC (Electronic Data Capture) vendor for clinical trial data management.
• VeevasupportingTechnology or IntegrationIndero uses Veeva as a qualified EDC (Electronic Data Capture) vendor for clinical trial data management.
• Signant HealthsupportingTechnology or IntegrationIndero uses Signant Health as a qualified eCOA (electronic Clinical Outcome Assessment) and EDC vendor for clinical trial data capture.
• SuvodasupportingTechnology or IntegrationIndero uses Suvoda as a qualified IRT (Interactive Response Technology) vendor for randomization and trial supply management.
• Innovaderm (CRU)coreStrategic or Co-development PartnerInnovaderm is Indero's affiliated Clinical Research Unit (CRU), a dedicated dermatology-focused clinical research site conducting single or multicenter dermatology studies. With a database of 90,000+ patients, it provides single-center study capacity with dedicated coordinators, lab technicians, nurses, and recruitment professionals, offering synergy and competitive pricing advantages.
• OraclesupportingTechnology or IntegrationOracle Argus Safety is implemented and validated for pharmacovigilance operations, compliant with ISO security and quality certifications (ISO 9001, ISO 27001, ISO 27017, ISO 27018).

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Medpace: Mid-sized full-service CRO known for therapeutic expertise and operational efficiency across multiple indications including immunology. Comparable to Indero in mid-market positioning, sponsor focus on biotech, and reputation for disciplined execution.
• Ergomed: Specialty CRO with strong oncology and immunology presence, providing full-service clinical research and pharmacovigilance. Comparable to Indero as a therapeutically focused mid-market CRO serving similar biotech and pharma sponsors.
• Biorasi: Specialty CRO focused on dermatology, oncology, and rare disease with global trial delivery. Highly comparable to Indero's dermatology focus and similar mid-market CRO model serving biotech sponsors.
• Worldwide Clinical Trials: Mid-sized specialty CRO with therapeutic expertise across multiple indications including immunology and rare disease. Highly comparable as a focused, science-driven CRO competing for biotech and pharma sponsors with similar operating model and project-based services.
• Celerion: Early-phase clinical research organization specializing in PK/PD and translational studies. Comparable to Indero's early phase and translational research capabilities, particularly for dermatology proof-of-concept studies.
• Veristat: Specialty clinical research organization with biostatistics, data management, and clinical trial expertise in rare disease and complex indications. Comparable to Indero's biometrics and clinical trial delivery model.
• Premier Research: Specialty CRO with established dermatology, rare disease, and analgesia franchises. Directly comparable to Indero as a therapeutically focused mid-market CRO serving biotech sponsors with end-to-end clinical trial services.

Broad incumbents

• IQVIA: The largest global CRO and life sciences services provider, offering full-service clinical research including dermatology and rheumatology capabilities. Broad incumbent competing for the same biotech and pharma sponsor relationships as Indero.
• ICON plc: One of the world's largest CROs offering full-service clinical research across all therapeutic areas. Comparable as a competitor for dermatology/rheumatology trials from a scale and global footprint perspective, though Indero's specialty focus is its differentiator.
• Parexel: Large global CRO with full-service clinical research, biostatistics, and regulatory capabilities across multiple therapeutic areas. Comparable as a broad incumbent that competes with specialty CROs like Indero for dermatology and rheumatology trial work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/innovaderm
• YouTubeyoutube.com/@inderoCRO
• LinkedInlinkedin.com/company/3239004

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Indero